University of Florida
Gainesville, Florida, 32605, United States
Location status: Recruiting
NCT Number: NCT06988995
Research has shown that LVAD patients and their caregivers typically experience increased mental health concerns and decreased quality of life following LVAD implantation and hospital discharge. The purpose of this study is to explore how to improve quality of life for LVAD patients and their caregivers in the initial transition from hospital to home after LVAD implantation.
Over the course of the study, participants will complete 2 surveys: one when participants are in the hospital and one at a 2-month post-hospital follow-up appointment with the participants' cardiologist. Participants may be contacted if there is data missing from surveys.
Participants may also be provided with information on improving mental health in the form of handouts or a brief meeting with a psychology provider.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Gainesville, Florida, 32605, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants provided handouts with information on self-compassion
Participants meet with a psychological provider to receive information on self-compassion and training on how to utilize self-compassion
Time frame: 2 months
Level of self-compassion a participant reports using the Self-Compassion Scale - Short Form (Raes et al., 2011). Scores range from 1-5.
Time frame: 2 months
Quality of Life will be measured using the 16 item Quality of Life Scale (Burckhardt et al., 1989). Scores range from 16-112, with higher scores indicating higher levels of quality of life.
Time frame: 2 months
Time frame: 2 months
The Cardiac Self-Efficacy Scale (Sullivan et al., 1998) is a 13-item measure that measures self-efficacy in patients with cardiac problems across 2 subscales: maintain and control. Scores are averaged across the two subscales. Scores range from 0-4, with higher scores indicating higher confidence or perceived self-efficacy.
Time frame: 2 months
General Self-efficacy will be measured by the General Self-Efficacy Scale (Weinman et al., 1995). The GSE is a 10-item scale with scores ranging from 10-40, with higher scores indicating more self-efficacy.
Time frame: 2 months
Illness denial will be measured using the Illness Denial Questionnaire. Caregivers will receive the caregiver version, and patients will receive the patient version. Both versions are 24-items, with scores ranging from 0-24. Higher scores indicate higher levels of denial
Time frame: 2 months
Time frame: 2 months
Caregiver burden will be assessed using the Zarit Burden Interview - Short Form, which is a 12 item questionnaire assessing caregiver burden. Scores range from 0-48, with a score over 20 indicating high burden.
Time frame: 2 months
Participants will be asked about the feasibility and acceptability of the intervention they receive. Scores range from 0-5, with higher scores indicating greater acceptability and higher feasibility (i.e., the intervention felt easy to complete and use).
University of Florida
Other
Compassion Strikes Back: Improving Dyadic Quality of Life for LVAD Patients and Caregivers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02248974
Bridge-to-Transplant LVAD Placement (BTT), Destination Therapy LVAD Placement (DT)
New Orleans, Louisiana, United States
View Trial DetailsNCT07652333
Body Weight, Muscle Composition
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06860763
ADHD - Attention Deficit Disorder With Hyperactivity, Acupuncture
Beijing, Chaoyang District, China
View Trial DetailsNCT07143539
Anxiety Depression, Anxiety Disorders
Aarau, Switzerland
View Trial Details